Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Histopathological comparison of Kearns-Sayre syndrome and PGC-1α-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy.
Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
Translational challenge models in support of efficacy studies: Neurobehavioral and cognitive changes induced by Transcranial Magnetic Stimulation in healthy volunteers.
Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy.
Regression-Based Norms for the Brief Visuospatial Memory Test-Revised in Italian population and application in MS patients.
Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking Injectable and Oral Disease Modifying Treatments in the United States.
Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways.
Cost-Effectiveness of Subcutaneous Verse Intramuscular Interferon Beta-1A In Portugal Based on the Findings of Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
ANNALS EXPRESS: Multiple Sclerosis: Assay of Free Immunoglobulin Light Chains.
Cost-Effectiveness of Subcutaneous Interferon Beta-1A in a Sub-Population of Multiple Sclerosis Patients (Kurtzke Expanded Disability Status Scale [EDSS]: >3.5-5.0).
Cognitive Impairment and Health Related Quality of Life in Relapsing Remitting Multiple Sclerosis.
Case Report of Lewis and Sumner Syndrome with Bilateral Vagus Nerves Paralysis for 16 Years.
Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core Findings.
The Impact of Adherence and Development of Neutralizing Antibodies to Interferons β on Treatment of Multiple Sclerosis in the Czech Republic.
High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases.
MAL Is a Regulator of the Recruitment of Myelin Protein PLP to Membrane Microdomains.
Comparing Characteristics of Hungarian "Real Life" Patients With Participants of RCTS: First-Line Disease Modifying Therapies in Multiple Sclerosis.
Short Term Reproducibility of a High Contrast 3-D Isotropic Optic Nerve Imaging Sequence in Healthy Controls.
Minimally Invasive En Bloc Resection of Massive Obstructive Atrial Tumour.
An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study.
Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity.
Validation of White-Matter Lesion Change Detection Methods on a Novel Publicly Available MRI Image Database.
Farming, Foreign Holidays, and Vitamin D in Orkney.
A Multimodal Intervention for Patients with Secondary Progressive Multiple Sclerosis: Feasibility and Effect on Fatigue.

Pages